| (S)-colchicine | decreases expression | EXP | | 6480464 | Colchicine results in decreased expression of CDKN3 mRNA | CTD | PMID:20624997 |
| 17alpha-ethynylestradiol | multiple interactions | ISO | RGD:1317173 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CDKN3 mRNA | CTD | PMID:17942748 |
| 17alpha-ethynylestradiol | affects expression | EXP | | 6480464 | Ethinyl Estradiol affects the expression of CDKN3 mRNA | CTD | PMID:17351261 |
| 17beta-estradiol | decreases expression | ISO | RGD:1317172 | 6480464 | Estradiol results in decreased expression of CDKN3 mRNA | CTD | PMID:16474171 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:1317173 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CDKN3 mRNA | CTD | PMID:17942748 |
| 2,3-dimethoxynaphthalene-1,4-dione | increases expression | ISO | RGD:1317172 | 6480464 | 2,3-dimethoxy-1,4-naphthoquinone results in increased expression of CDKN3 mRNA | CTD | PMID:17547211 |
| 2,6-dinitrotoluene | affects expression | EXP | | 6480464 | 2,6-dinitrotoluene affects the expression of CDKN3 mRNA | CTD | PMID:21346803 |
| 2-amino-2-deoxy-D-glucopyranose | decreases expression | EXP | | 6480464 | Glucosamine results in decreased expression of CDKN3 mRNA | CTD | PMID:17109745 |
| 3-methylcholanthrene | increases expression | ISO | RGD:1317173 | 6480464 | Methylcholanthrene results in increased expression of CDKN3 mRNA | CTD | PMID:20713471 |
| 5-fluorouracil | multiple interactions | ISO | RGD:1317172 | 6480464 | TP53 protein affects the reaction [Fluorouracil results in decreased expression of CDKN3 mRNA] | CTD | PMID:15016801 |
| aflatoxin B1 | affects expression | ISO | RGD:1317172 | 6480464 | Aflatoxin B1 affects the expression of CDKN3 protein | CTD | PMID:20106945 |
| aflatoxin B1 | decreases expression | ISO | RGD:1317173 | 6480464 | Aflatoxin B1 results in decreased expression of CDKN3 mRNA | CTD | PMID:19770486 |
| aldehydo-D-glucosamine | decreases expression | EXP | | 6480464 | Glucosamine results in decreased expression of CDKN3 mRNA | CTD | PMID:17109745 |
| all-trans-retinoic acid | decreases expression | ISO | RGD:1317172 | 6480464 | Tretinoin results in decreased expression of CDKN3 mRNA | CTD | PMID:21934132 |
| antimony(0) | increases expression | ISO | RGD:1317172 | 6480464 | Antimony results in increased expression of CDKN3 mRNA | CTD | PMID:17547211 |
| beta-D-glucosamine | decreases expression | EXP | | 6480464 | Glucosamine results in decreased expression of CDKN3 mRNA | CTD | PMID:17109745 |
| bisphenol A | decreases expression | ISO | RGD:1317172 | 6480464 | bisphenol A results in decreased expression of CDKN3 mRNA | CTD | PMID:16474171 |
| cadmium dichloride | decreases expression | ISO | RGD:1317173 | 6480464 | Cadmium Chloride results in decreased expression of CDKN3 mRNA | CTD | PMID:20061341 |
| calcitriol | decreases expression | ISO | RGD:1317172 | 6480464 | Calcitriol results in decreased expression of CDKN3 mRNA | CTD | PMID:21592394 |
| calcitriol | multiple interactions | ISO | RGD:1317172 | 6480464 | [Testosterone co-treated with Calcitriol] results in decreased expression of CDKN3 mRNA | CTD | PMID:21592394 |
| carmustine | decreases expression | EXP | | 6480464 | Carmustine results in decreased expression of CDKN3 mRNA | CTD | PMID:16005536 |
| cisplatin | multiple interactions | ISO | RGD:1317172 | 6480464 | [Piroxicam co-treated with Cisplatin] results in decreased expression of CDKN3 mRNA | CTD | PMID:21858171 |
| coumarin | decreases expression | EXP | | 6480464 | coumarin results in decreased expression of CDKN3 mRNA | CTD | PMID:18480146 |
| cyclosporin A | affects expression | ISO | RGD:1317172 | 6480464 | Cyclosporine affects the expression of CDKN3 mRNA | CTD | PMID:20106945 |
| dasatinib (anhydrous) | decreases expression | ISO | RGD:1317172 | 6480464 | dasatinib results in decreased expression of CDKN3 mRNA | CTD | PMID:20579391 |
| dexamethasone | multiple interactions | EXP | | 6480464 | Testosterone inhibits the reaction [Dexamethasone results in decreased expression of CDKN3 mRNA] | CTD | PMID:20032058 |
| dexamethasone | decreases expression | EXP | | 6480464 | Dexamethasone results in decreased expression of CDKN3 mRNA | CTD | PMID:20032058 |
| diarsenic trioxide | increases expression | ISO | RGD:1317172 | 6480464 | arsenic trioxide results in increased expression of CDKN3 mRNA | CTD | PMID:17547211 |
| dibutyl phthalate | decreases expression | EXP | | 6480464 | Dibutyl Phthalate results in decreased expression of CDKN3 mRNA | CTD | PMID:21266533 |
| dipotassium bis[mu-tartrato(4-)]diantimonate(2-) trihydrate | increases expression | ISO | RGD:1317172 | 6480464 | Antimony Potassium Tartrate results in increased expression of CDKN3 mRNA | CTD | PMID:17547211 |
| disodium selenite | decreases expression | ISO | RGD:1317172 | 6480464 | Sodium Selenite results in decreased expression of CDKN3 mRNA | CTD | PMID:18175754 |
| genistein | decreases expression | ISO | RGD:1317172 | 6480464 | Genistein results in decreased expression of CDKN3 mRNA | CTD | PMID:16474171 |
| lucanthone | decreases expression | ISO | RGD:1317172 | 6480464 | Lucanthone results in decreased expression of CDKN3 mRNA | CTD | PMID:21148553 |
| manganese atom | decreases expression | ISO | RGD:1317172 | 6480464 | Manganese results in decreased expression of CDKN3 mRNA | CTD | PMID:17175027 |
| manganese(0) | decreases expression | ISO | RGD:1317172 | 6480464 | Manganese results in decreased expression of CDKN3 mRNA | CTD | PMID:17175027 |
| manganese(II) chloride | decreases expression | ISO | RGD:1317172 | 6480464 | manganese chloride results in decreased expression of CDKN3 mRNA | CTD | PMID:17175027 |
| mercury atom | increases expression | ISO | RGD:1317172 | 6480464 | Mercury results in increased expression of CDKN3 mRNA | CTD | PMID:17547211 |
| mercury(0) | increases expression | ISO | RGD:1317172 | 6480464 | Mercury results in increased expression of CDKN3 mRNA | CTD | PMID:17547211 |
| methotrexate | decreases expression | EXP | | 6480464 | Methotrexate results in decreased expression of CDKN3 mRNA | CTD | PMID:16005536 |
| methylmercury chloride | decreases expression | ISO | RGD:1317173 | 6480464 | methylmercuric chloride results in decreased expression of CDKN3 mRNA | CTD | PMID:20061341 |
| perfluorooctanoic acid | increases expression | ISO | RGD:1317173 | 6480464 | perfluorooctanoic acid results in increased expression of CDKN3 mRNA | CTD | PMID:18467677 |
| perfluorooctanoic acid | multiple interactions | ISO | RGD:1317173 | 6480464 | PPARA protein promotes the reaction [perfluorooctanoic acid results in increased expression of CDKN3 mRNA] | CTD | PMID:18467677 |
| phenobarbital | multiple interactions | ISO | RGD:1317173 | 6480464 | NR1I3 protein affects the reaction [Phenobarbital results in increased expression of CDKN3 mRNA] | CTD | PMID:19482888 |
| phenobarbital | increases expression | ISO | RGD:1317173 | 6480464 | Phenobarbital results in increased expression of CDKN3 mRNA | CTD | PMID:20403969 PMID:19482888 |
| phenobarbital | increases expression | ISO | RGD:1317173 | 6480464 | Phenobarbital results in increased expression of CDKN3 mRNA | CTD | PMID:19482888 PMID:20403969 |
| pirinixic acid | increases expression | ISO | RGD:1317173 | 6480464 | pirinixic acid results in increased expression of CDKN3 mRNA | CTD | PMID:18467677 |
| pirinixic acid | multiple interactions | ISO | RGD:1317173 | 6480464 | PPARA protein promotes the reaction [pirinixic acid results in increased expression of CDKN3 mRNA] | CTD | PMID:18467677 |
| piroxicam | multiple interactions | ISO | RGD:1317172 | 6480464 | [Piroxicam co-treated with Cisplatin] results in decreased expression of CDKN3 mRNA | CTD | PMID:21858171 |
| tert-butyl hydroperoxide | increases expression | ISO | RGD:1317173 | 6480464 | tert-Butylhydroperoxide results in increased expression of CDKN3 mRNA | CTD | PMID:15003993 |
| testosterone | decreases expression | ISO | RGD:1317172 | 6480464 | Testosterone results in decreased expression of CDKN3 mRNA | CTD | PMID:21592394 |
| testosterone | multiple interactions | EXP | | 6480464 | Testosterone inhibits the reaction [Dexamethasone results in decreased expression of CDKN3 mRNA] | CTD | PMID:20032058 |
| testosterone | multiple interactions | ISO | RGD:1317172 | 6480464 | [Testosterone co-treated with Calcitriol] results in decreased expression of CDKN3 mRNA | CTD | PMID:21592394 |
| tetrachloromethane | increases expression | ISO | RGD:1317173 | 6480464 | Carbon Tetrachloride results in increased expression of CDKN3 mRNA | CTD | PMID:17484886 |
| trimellitic anhydride | increases expression | ISO | RGD:1317173 | 6480464 | trimellitic anhydride results in increased expression of CDKN3 mRNA | CTD | PMID:19042947 |
| troglitazone | decreases expression | ISO | RGD:1317172 | 6480464 | troglitazone results in decreased expression of CDKN3 mRNA | CTD | PMID:19140230 |
| vincaleukoblastine | decreases expression | EXP | | 6480464 | Vinblastine results in decreased expression of CDKN3 mRNA | CTD | PMID:20624997 |